Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Study protocol: Phase I/II trial of induced HLA-G+ regulatory T cells in patients undergoing allogeneic hematopoietic cell transplantation from an HLA-matched sibling donor.
Lysandrou M, Kefala D, Christofi P, Savvopoulos N, Papayanni PG, Theodorellou R, Sagiadinou E, Zacharioudaki V, Moukouli M, Tsokanas D, Karavalakis G, Liga M, Stavrinos K, Papadopoulou A, Yannaki E, Spyridonidis A. Lysandrou M, et al. Among authors: spyridonidis a. Front Med (Lausanne). 2023 May 19;10:1166871. doi: 10.3389/fmed.2023.1166871. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37275377 Free PMC article.
Hypomethylation-induced regulatory programs in T cells unveiled by transcriptomic analyses.
Lysandrou M, Stamou P, Kefala D, Pierides C, Kyriakou M, Savvopoulos N, Christofi P, Papadopoulou A, Yannaki E, Costeas P, Spyridonidis A. Lysandrou M, et al. Among authors: spyridonidis a. Front Immunol. 2023 Sep 27;14:1235661. doi: 10.3389/fimmu.2023.1235661. eCollection 2023. Front Immunol. 2023. PMID: 37828996 Free PMC article.
A GMP-Compliant Procedure for the Generation of Gene-Modified T cells.
Savvopoulos N, Stampolitis K, Alexandropoulos G, Kefala D, Lysandrou M, Zacharioudaki V, Tsolakos N, Spyridonidis A. Savvopoulos N, et al. Among authors: spyridonidis a. J Vis Exp. 2023 Oct 6;(200). doi: 10.3791/65097. J Vis Exp. 2023. PMID: 37870303
Solid tumor transmission from donor to recipient after allogeneic stem cell transplantation: it is rare but it happens!
Tsirigotis P, Spyridonidis A, Gkirkas K, Chondropoulos S, Rondogianni P, Thomopoulos T, Karagiannidou A, Vythoulkas D, Griniezaki M, Georgakopoulos N, Stamouli M, Foukas PG. Tsirigotis P, et al. Among authors: spyridonidis a. Blood Transfus. 2023 Sep;21(5):437-440. doi: 10.2450/BloodTransfus.498. Epub 2023 Mar 10. Blood Transfus. 2023. PMID: 37146299 Free PMC article. No abstract available.
Clinical outcomes in vaccinated and unvaccinated patients with COVID-19: a population-based analysis.
Papaioannou O, Karampitsakos T, Tsiri P, Sotiropoulou V, Koulousousa E, Tasiopoulos P, Schinas G, Katsaras M, Zarkadi E, Malakounidou E, Georgiopoulou V, Sampsonas F, Spyridonidis A, Akinosoglou K, Marangos M, Tzouvelekis A. Papaioannou O, et al. Among authors: spyridonidis a. Eur Rev Med Pharmacol Sci. 2022 Oct;26(20):7705-7712. doi: 10.26355/eurrev_202210_30047. Eur Rev Med Pharmacol Sci. 2022. PMID: 36314348 Free article.
Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT.
Spyridonidis A, Labopin M, Savani B, Giebel S, Bug G, Schönland S, Kröger N, Stelljes M, Schroeder T, McDonald A, Blau IW, Bornhäuser M, Rovira M, Bethge W, Neubauer A, Ganser A, Bourhis JH, Edinger M, Lioure B, Wulf G, Schäfer-Eckart K, Arat M, Peric Z, Schmid C, Bazarbachi A, Ciceri F, Nagler A, Mohty M. Spyridonidis A, et al. Hemasphere. 2023 Jan 9;7(1):e812. doi: 10.1097/HS9.0000000000000812. eCollection 2023 Jan. Hemasphere. 2023. PMID: 36698616 Free PMC article.
Thiotepa-busulfan-fludarabine Compared to Treosulfan-based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMT.
Saraceni F, Labopin M, Raiola AM, Blaise D, Reményi P, Sorà F, Pavlu J, Bramanti S, Busca A, Berceanu A, Battipaglia G, Visani G, Sociè G, Bug G, Micò C, La Nasa G, Musso M, Olivieri A, Spyridonidis A, Savani B, Ciceri F, Nagler A, Mohty M. Saraceni F, et al. Among authors: spyridonidis a. Hemasphere. 2023 Sep 20;7(10):e952. doi: 10.1097/HS9.0000000000000952. eCollection 2023 Oct. Hemasphere. 2023. PMID: 37746158 Free PMC article.
Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A, Labopin M, Swoboda R, Schroeder T, Hamladji RM, Griskevicius L, Salmenniemi U, Rambaldi A, Mielke S, Kulagin A, Passweg J, Luft T, Gedde-Dahl T, Forcade E, Helbig G, Stelljes M, Castilla-Llorente C, Spyridonidis A, Brissot E, Ciceri F, Mohty M. Nagler A, et al. Among authors: spyridonidis a. Bone Marrow Transplant. 2024 Apr 13. doi: 10.1038/s41409-024-02284-5. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38615143
137 results